Acteoside as a potential therapeutic option for primary hepatocellular carcinoma: A preclinical study
Số trang: 11
Loại file: pdf
Dung lượng: 2.99 MB
Lượt xem: 10
Lượt tải: 0
Xem trước 2 trang đầu tiên của tài liệu này:
Thông tin tài liệu:
Hepatocellular carcinoma (HCC) is a common malignant tumor with characteristics of poor prognosis, high morbidity and mortality worldwide. In particular, only a few systemic treatment options are available for advanced HCC patients, and include sorafenib and the recently described atezolizumab plus bevacizumab regimen as possible first-line treatments.
Nội dung trích xuất từ tài liệu:
Acteoside as a potential therapeutic option for primary hepatocellular carcinoma: A preclinical study
Nội dung trích xuất từ tài liệu:
Acteoside as a potential therapeutic option for primary hepatocellular carcinoma: A preclinical study
Tìm kiếm theo từ khóa liên quan:
BMC Cancer Hepatocellular carcinoma Malignant tumor Mortality worldwide Systemic treatment Kallikrein-related peptidaseGợi ý tài liệu liên quan:
-
Differences between physician and patient preferences for cancer treatments: A systematic review
13 trang 167 0 0 -
6 trang 166 0 0
-
Immune checkpoint inhibitors and their impact on liver enzymes and attenuation
7 trang 139 0 0 -
2011–2021 rising prevalence of HPV infection among oropharyngeal carcinoma in France
9 trang 109 0 0 -
12 trang 87 0 0
-
19 trang 72 0 0
-
17 trang 60 0 0
-
9 trang 35 0 0
-
11 trang 35 0 0
-
12 trang 33 0 0